Onco404
@onco404.bsky.social
Your resource dedicated to personalized cancer care: Curated news, key scientific articles, and analyses.
📌 OncoTerm - Word of the Day! 👋 OncoTerm - Günün Kelimesi! 📌
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #Cancer #Kanser #Oncology #GeriatricOncology #Oncogeriatrics #CancerCare #MedSky #OncSky #MedNews #Vocabulary
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #Cancer #Kanser #Oncology #GeriatricOncology #Oncogeriatrics #CancerCare #MedSky #OncSky #MedNews #Vocabulary
July 3, 2025 at 8:40 AM
📌 OncoTerm - Word of the Day! 👋 OncoTerm - Günün Kelimesi! 📌
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #Cancer #Kanser #Oncology #GeriatricOncology #Oncogeriatrics #CancerCare #MedSky #OncSky #MedNews #Vocabulary
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #Cancer #Kanser #Oncology #GeriatricOncology #Oncogeriatrics #CancerCare #MedSky #OncSky #MedNews #Vocabulary
📌 OncoTerm - Word of the Day! 👋 OncoTerm - Günün Kelimesi! 📌
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #Cancer #Kanser #Oncology #CancerAwareness #CancerCare #ParaneoplasticSyndrome #PNS #MedSky #OncSky #Vocabulary
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #Cancer #Kanser #Oncology #CancerAwareness #CancerCare #ParaneoplasticSyndrome #PNS #MedSky #OncSky #Vocabulary
June 27, 2025 at 9:54 AM
📌 OncoTerm - Word of the Day! 👋 OncoTerm - Günün Kelimesi! 📌
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #Cancer #Kanser #Oncology #CancerAwareness #CancerCare #ParaneoplasticSyndrome #PNS #MedSky #OncSky #Vocabulary
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #Cancer #Kanser #Oncology #CancerAwareness #CancerCare #ParaneoplasticSyndrome #PNS #MedSky #OncSky #Vocabulary
📌 OncoTerm - Word of the Day! 👋 OncoTerm - Günün Kelimesi! 📌
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #Cancer #Kanser #Oncology #MedSky #OncSky #CancerAwareness #InvestigationalNewDrug #IND #FDA #ClinicalTrials #Vocabulary
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #Cancer #Kanser #Oncology #MedSky #OncSky #CancerAwareness #InvestigationalNewDrug #IND #FDA #ClinicalTrials #Vocabulary
June 26, 2025 at 7:51 AM
📌 OncoTerm - Word of the Day! 👋 OncoTerm - Günün Kelimesi! 📌
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #Cancer #Kanser #Oncology #MedSky #OncSky #CancerAwareness #InvestigationalNewDrug #IND #FDA #ClinicalTrials #Vocabulary
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #Cancer #Kanser #Oncology #MedSky #OncSky #CancerAwareness #InvestigationalNewDrug #IND #FDA #ClinicalTrials #Vocabulary
The TuPro study used 9 #multiomics technologies (scRNA-seq, proteomics, etc.) to profile 116 #melanoma patients, generating >40,000 markers/sample in just 4 weeks.
@natureportfolio.nature.com
#Onco404 #Cancer #Kanser #PrecisionOncology #ClinicalTrials #TumorProfiling #MedSky #OncSky #ASCO2025
@natureportfolio.nature.com
#Onco404 #Cancer #Kanser #PrecisionOncology #ClinicalTrials #TumorProfiling #MedSky #OncSky #ASCO2025
May 30, 2025 at 1:06 PM
The TuPro study used 9 #multiomics technologies (scRNA-seq, proteomics, etc.) to profile 116 #melanoma patients, generating >40,000 markers/sample in just 4 weeks.
@natureportfolio.nature.com
#Onco404 #Cancer #Kanser #PrecisionOncology #ClinicalTrials #TumorProfiling #MedSky #OncSky #ASCO2025
@natureportfolio.nature.com
#Onco404 #Cancer #Kanser #PrecisionOncology #ClinicalTrials #TumorProfiling #MedSky #OncSky #ASCO2025
📌 OncoTerm - Word of the Day! 👋 OncoTerm - Günün Kelimesi! 📌
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #Cancer #Kanser #MedSky #OncSky #CancerAwareness #CancerCare #Chemokine #ImmuneSystem #ImmuneResponse #TumorImmunity #Vocabulary
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #Cancer #Kanser #MedSky #OncSky #CancerAwareness #CancerCare #Chemokine #ImmuneSystem #ImmuneResponse #TumorImmunity #Vocabulary
May 30, 2025 at 6:59 AM
📌 OncoTerm - Word of the Day! 👋 OncoTerm - Günün Kelimesi! 📌
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #Cancer #Kanser #MedSky #OncSky #CancerAwareness #CancerCare #Chemokine #ImmuneSystem #ImmuneResponse #TumorImmunity #Vocabulary
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #Cancer #Kanser #MedSky #OncSky #CancerAwareness #CancerCare #Chemokine #ImmuneSystem #ImmuneResponse #TumorImmunity #Vocabulary
This integrated analysis of CodeBreaK 100 & 200 trials delves into biomarkers influencing sotorasib efficacy in KRAS G12C-mutated NSCLC.
#NatureMedicine
#Onco404 #Cancer #Kanser #LungCancer #Sotorasib #NSCLC #Biomarkers #PrecisionOncology #KRAS #TTF1 #KEAP1 #NRF2 #NFE2L2 #MedSky #OncSky
#NatureMedicine
#Onco404 #Cancer #Kanser #LungCancer #Sotorasib #NSCLC #Biomarkers #PrecisionOncology #KRAS #TTF1 #KEAP1 #NRF2 #NFE2L2 #MedSky #OncSky
May 29, 2025 at 3:40 PM
This integrated analysis of CodeBreaK 100 & 200 trials delves into biomarkers influencing sotorasib efficacy in KRAS G12C-mutated NSCLC.
#NatureMedicine
#Onco404 #Cancer #Kanser #LungCancer #Sotorasib #NSCLC #Biomarkers #PrecisionOncology #KRAS #TTF1 #KEAP1 #NRF2 #NFE2L2 #MedSky #OncSky
#NatureMedicine
#Onco404 #Cancer #Kanser #LungCancer #Sotorasib #NSCLC #Biomarkers #PrecisionOncology #KRAS #TTF1 #KEAP1 #NRF2 #NFE2L2 #MedSky #OncSky
📌 OncoTerm - Word of the Day! 👋 OncoTerm - Günün Kelimesi! 📌
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #Cancer #Kanser #CancerAwareness #Cytokine #ImmuneSystem #CancerCare #Inflammation #MedSky #OncSky #Vocabulary
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #Cancer #Kanser #CancerAwareness #Cytokine #ImmuneSystem #CancerCare #Inflammation #MedSky #OncSky #Vocabulary
May 29, 2025 at 7:52 AM
📌 OncoTerm - Word of the Day! 👋 OncoTerm - Günün Kelimesi! 📌
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #Cancer #Kanser #CancerAwareness #Cytokine #ImmuneSystem #CancerCare #Inflammation #MedSky #OncSky #Vocabulary
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #Cancer #Kanser #CancerAwareness #Cytokine #ImmuneSystem #CancerCare #Inflammation #MedSky #OncSky #Vocabulary
A cluster randomized trial tested if algorithm-based EHR defaults with accountable justification could increase specialty palliative care (PC) consultations.
@JAMANetworkOpen #JAMA
#Onco404 #Cancer #Kanser #Hospice #PalliativeCare #SupportiveCare #MedSky #OncSky #Healthcare #DigitalHealth
@JAMANetworkOpen #JAMA
#Onco404 #Cancer #Kanser #Hospice #PalliativeCare #SupportiveCare #MedSky #OncSky #Healthcare #DigitalHealth
May 28, 2025 at 3:45 PM
A cluster randomized trial tested if algorithm-based EHR defaults with accountable justification could increase specialty palliative care (PC) consultations.
@JAMANetworkOpen #JAMA
#Onco404 #Cancer #Kanser #Hospice #PalliativeCare #SupportiveCare #MedSky #OncSky #Healthcare #DigitalHealth
@JAMANetworkOpen #JAMA
#Onco404 #Cancer #Kanser #Hospice #PalliativeCare #SupportiveCare #MedSky #OncSky #Healthcare #DigitalHealth
📌 OncoTerm - Word of the Day! 👋 OncoTerm - Günün Kelimesi! 📌
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #Cancer #Kanser #CancerAwareness #Hospice #YaşamSonuBakımı #PalliativeCare #PalyatifBakım #QoL #MedSky #OncSky #Vocabulary
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #Cancer #Kanser #CancerAwareness #Hospice #YaşamSonuBakımı #PalliativeCare #PalyatifBakım #QoL #MedSky #OncSky #Vocabulary
May 28, 2025 at 8:06 AM
📌 OncoTerm - Word of the Day! 👋 OncoTerm - Günün Kelimesi! 📌
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #Cancer #Kanser #CancerAwareness #Hospice #YaşamSonuBakımı #PalliativeCare #PalyatifBakım #QoL #MedSky #OncSky #Vocabulary
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #Cancer #Kanser #CancerAwareness #Hospice #YaşamSonuBakımı #PalliativeCare #PalyatifBakım #QoL #MedSky #OncSky #Vocabulary
A new study analyzed 233 trials associated with 207 FDA approvals (2015–2020) and found alarming gaps in health-related quality of life (HRQoL) reporting.
#BMJ #BMJOncology
#Onco404 #Cancer #Kanser #Oncology #ClinicalTrials #FDA #QoL #HRQoL #MedSky #OncSky #PatientReportedOutcomes
#BMJ #BMJOncology
#Onco404 #Cancer #Kanser #Oncology #ClinicalTrials #FDA #QoL #HRQoL #MedSky #OncSky #PatientReportedOutcomes
May 27, 2025 at 3:56 PM
A new study analyzed 233 trials associated with 207 FDA approvals (2015–2020) and found alarming gaps in health-related quality of life (HRQoL) reporting.
#BMJ #BMJOncology
#Onco404 #Cancer #Kanser #Oncology #ClinicalTrials #FDA #QoL #HRQoL #MedSky #OncSky #PatientReportedOutcomes
#BMJ #BMJOncology
#Onco404 #Cancer #Kanser #Oncology #ClinicalTrials #FDA #QoL #HRQoL #MedSky #OncSky #PatientReportedOutcomes
📌 OncoTerm - Word of the Day! 👋 OncoTerm - Günün Kelimesi! 📌
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #Cancer #Kanser #MedSky #OncSky #PatientCenteredCare #CancerCare #QualityOfLife #QoL #PatientReportedOutcomes #PROs #Vocabulary
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #Cancer #Kanser #MedSky #OncSky #PatientCenteredCare #CancerCare #QualityOfLife #QoL #PatientReportedOutcomes #PROs #Vocabulary
May 27, 2025 at 5:29 AM
📌 OncoTerm - Word of the Day! 👋 OncoTerm - Günün Kelimesi! 📌
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #Cancer #Kanser #MedSky #OncSky #PatientCenteredCare #CancerCare #QualityOfLife #QoL #PatientReportedOutcomes #PROs #Vocabulary
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #Cancer #Kanser #MedSky #OncSky #PatientCenteredCare #CancerCare #QualityOfLife #QoL #PatientReportedOutcomes #PROs #Vocabulary
The phase III MITO-23 trial compared trabectedin monotherapy to physician’s choice chemo in 244 patients with BRCA-mutated or BRCAness recurrent ovarian cancer.
@ascocancer.bsky.social #JCO #ASCO
#Onco404 #Cancer #Kanser #OvarianCancer #MedSky #OncSky #BRCA #BRCAness #Trabectedin #ClinicalTrials
@ascocancer.bsky.social #JCO #ASCO
#Onco404 #Cancer #Kanser #OvarianCancer #MedSky #OncSky #BRCA #BRCAness #Trabectedin #ClinicalTrials
May 26, 2025 at 3:58 PM
The phase III MITO-23 trial compared trabectedin monotherapy to physician’s choice chemo in 244 patients with BRCA-mutated or BRCAness recurrent ovarian cancer.
@ascocancer.bsky.social #JCO #ASCO
#Onco404 #Cancer #Kanser #OvarianCancer #MedSky #OncSky #BRCA #BRCAness #Trabectedin #ClinicalTrials
@ascocancer.bsky.social #JCO #ASCO
#Onco404 #Cancer #Kanser #OvarianCancer #MedSky #OncSky #BRCA #BRCAness #Trabectedin #ClinicalTrials
📌 OncoTerm - Word of the Day! 👋 OncoTerm - Günün Kelimesi! 📌
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #Cancer #Kanser #MedSky #OncSky #BRCAness #HRD #BRCA1 #BRCA2 #PlatinumChemotherapy #PARPInhibitor #TargetedTherapy #Vocabulary
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #Cancer #Kanser #MedSky #OncSky #BRCAness #HRD #BRCA1 #BRCA2 #PlatinumChemotherapy #PARPInhibitor #TargetedTherapy #Vocabulary
May 26, 2025 at 8:04 AM
📌 OncoTerm - Word of the Day! 👋 OncoTerm - Günün Kelimesi! 📌
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #Cancer #Kanser #MedSky #OncSky #BRCAness #HRD #BRCA1 #BRCA2 #PlatinumChemotherapy #PARPInhibitor #TargetedTherapy #Vocabulary
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #Cancer #Kanser #MedSky #OncSky #BRCAness #HRD #BRCA1 #BRCA2 #PlatinumChemotherapy #PARPInhibitor #TargetedTherapy #Vocabulary
📌 "OncoTerm - Word of the Day" - WEEKLY DIGEST (May 19-25)👋
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #OncoTerm #Oncology #Cancer #Kanser #CancerAwareness #Healthcare #FightCancer #MedSky #OncSky #Vocabulary
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #OncoTerm #Oncology #Cancer #Kanser #CancerAwareness #Healthcare #FightCancer #MedSky #OncSky #Vocabulary
May 26, 2025 at 7:17 AM
📌 "OncoTerm - Word of the Day" - WEEKLY DIGEST (May 19-25)👋
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #OncoTerm #Oncology #Cancer #Kanser #CancerAwareness #Healthcare #FightCancer #MedSky #OncSky #Vocabulary
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #OncoTerm #Oncology #Cancer #Kanser #CancerAwareness #Healthcare #FightCancer #MedSky #OncSky #Vocabulary
📌 “OncoTerm - Günün Kelimesi” - HAFTALIK ÖZET (19-25 Mayıs) 👋
Kansere karşı mücadelede kendimizi bilgiyle güçlendirmek için temel terimleri açıklarken bize katılın.
#Onco404 #OncoTerm #Oncology #Cancer #Kanser #CancerAwareness #Healthcare #FightCancer #Vocabulary
Kansere karşı mücadelede kendimizi bilgiyle güçlendirmek için temel terimleri açıklarken bize katılın.
#Onco404 #OncoTerm #Oncology #Cancer #Kanser #CancerAwareness #Healthcare #FightCancer #Vocabulary
May 26, 2025 at 7:09 AM
📌 “OncoTerm - Günün Kelimesi” - HAFTALIK ÖZET (19-25 Mayıs) 👋
Kansere karşı mücadelede kendimizi bilgiyle güçlendirmek için temel terimleri açıklarken bize katılın.
#Onco404 #OncoTerm #Oncology #Cancer #Kanser #CancerAwareness #Healthcare #FightCancer #Vocabulary
Kansere karşı mücadelede kendimizi bilgiyle güçlendirmek için temel terimleri açıklarken bize katılın.
#Onco404 #OncoTerm #Oncology #Cancer #Kanser #CancerAwareness #Healthcare #FightCancer #Vocabulary
This phase II study assessed encorafenib + binimetinib (BRAFi/MEKi), followed by the addition of a third targeted agent based on genomic alterations at progression
@theaacr.bsky.social #CCR
#Onco404 #Cancer #Kanser #Melanoma #TargetedTherapy #ClinicalTrials #BRAF #PrecisionMedicine #MedSky #OncSky
@theaacr.bsky.social #CCR
#Onco404 #Cancer #Kanser #Melanoma #TargetedTherapy #ClinicalTrials #BRAF #PrecisionMedicine #MedSky #OncSky
May 25, 2025 at 4:01 PM
This phase II study assessed encorafenib + binimetinib (BRAFi/MEKi), followed by the addition of a third targeted agent based on genomic alterations at progression
@theaacr.bsky.social #CCR
#Onco404 #Cancer #Kanser #Melanoma #TargetedTherapy #ClinicalTrials #BRAF #PrecisionMedicine #MedSky #OncSky
@theaacr.bsky.social #CCR
#Onco404 #Cancer #Kanser #Melanoma #TargetedTherapy #ClinicalTrials #BRAF #PrecisionMedicine #MedSky #OncSky
This May, Onco404 honors every unique journey touched by melanoma and skin cancer 🏅
Every step forward, every shared story, fuels our collective hope 🕊️ You are not alone 🖤
#Onco404 #Cancer #Kanser #Melanoma #MelanomaAwarenessMonth #SkinCancerAwarenessMonth #Hope #MedSky #OncSky
Every step forward, every shared story, fuels our collective hope 🕊️ You are not alone 🖤
#Onco404 #Cancer #Kanser #Melanoma #MelanomaAwarenessMonth #SkinCancerAwarenessMonth #Hope #MedSky #OncSky
May 25, 2025 at 9:30 AM
This May, Onco404 honors every unique journey touched by melanoma and skin cancer 🏅
Every step forward, every shared story, fuels our collective hope 🕊️ You are not alone 🖤
#Onco404 #Cancer #Kanser #Melanoma #MelanomaAwarenessMonth #SkinCancerAwarenessMonth #Hope #MedSky #OncSky
Every step forward, every shared story, fuels our collective hope 🕊️ You are not alone 🖤
#Onco404 #Cancer #Kanser #Melanoma #MelanomaAwarenessMonth #SkinCancerAwarenessMonth #Hope #MedSky #OncSky
📌 OncoTerm - Word of the Day! 👋 OncoTerm - Günün Kelimesi! 📌
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #Cancer #Kanser #CancerAwareness #CancerPrevalence #CancerPrevention #CancerScreening #PublicHealth #Healthcare #Vocabulary
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #Cancer #Kanser #CancerAwareness #CancerPrevalence #CancerPrevention #CancerScreening #PublicHealth #Healthcare #Vocabulary
May 25, 2025 at 8:45 AM
📌 OncoTerm - Word of the Day! 👋 OncoTerm - Günün Kelimesi! 📌
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #Cancer #Kanser #CancerAwareness #CancerPrevalence #CancerPrevention #CancerScreening #PublicHealth #Healthcare #Vocabulary
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #Cancer #Kanser #CancerAwareness #CancerPrevalence #CancerPrevention #CancerScreening #PublicHealth #Healthcare #Vocabulary
The final analysis of the INTRIGUE phase III trial reveals ripretinib and sunitinib show comparable overall survival in advanced GIST patients post-imatinib.
@ascocancer.bsky.social #JCO #ASCO
#Onco404 #Cancer #Kanser #GIST #Ripretinib #Sunitinib #ClinicalTrials #MedSky #OncSky
@ascocancer.bsky.social #JCO #ASCO
#Onco404 #Cancer #Kanser #GIST #Ripretinib #Sunitinib #ClinicalTrials #MedSky #OncSky
May 24, 2025 at 4:23 PM
The final analysis of the INTRIGUE phase III trial reveals ripretinib and sunitinib show comparable overall survival in advanced GIST patients post-imatinib.
@ascocancer.bsky.social #JCO #ASCO
#Onco404 #Cancer #Kanser #GIST #Ripretinib #Sunitinib #ClinicalTrials #MedSky #OncSky
@ascocancer.bsky.social #JCO #ASCO
#Onco404 #Cancer #Kanser #GIST #Ripretinib #Sunitinib #ClinicalTrials #MedSky #OncSky
📌 OncoTerm - Word of the Day! 👋 OncoTerm - Günün Kelimesi! 📌
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer
#Onco404 #Cancer #Kanser #CancerAwareness #Incidence #CancerIncidence #CancerPrevention #CancerScreening #PublicHealth #MedSky #Vocabulary
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer
#Onco404 #Cancer #Kanser #CancerAwareness #Incidence #CancerIncidence #CancerPrevention #CancerScreening #PublicHealth #MedSky #Vocabulary
May 24, 2025 at 1:09 PM
📌 OncoTerm - Word of the Day! 👋 OncoTerm - Günün Kelimesi! 📌
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer
#Onco404 #Cancer #Kanser #CancerAwareness #Incidence #CancerIncidence #CancerPrevention #CancerScreening #PublicHealth #MedSky #Vocabulary
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer
#Onco404 #Cancer #Kanser #CancerAwareness #Incidence #CancerIncidence #CancerPrevention #CancerScreening #PublicHealth #MedSky #Vocabulary
📌 OncoTerm - Word of the Day! 👋 OncoTerm - Günün Kelimesi! 📌
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #Cancer #Kanser #TP53 #LiFraumeniSyndrome #CancerPrevention #Sarcoma #BreastCancer #Leukemia #BrainTumors #ACC #Vocabulary
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #Cancer #Kanser #TP53 #LiFraumeniSyndrome #CancerPrevention #Sarcoma #BreastCancer #Leukemia #BrainTumors #ACC #Vocabulary
May 23, 2025 at 7:50 AM
📌 OncoTerm - Word of the Day! 👋 OncoTerm - Günün Kelimesi! 📌
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #Cancer #Kanser #TP53 #LiFraumeniSyndrome #CancerPrevention #Sarcoma #BreastCancer #Leukemia #BrainTumors #ACC #Vocabulary
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #Cancer #Kanser #TP53 #LiFraumeniSyndrome #CancerPrevention #Sarcoma #BreastCancer #Leukemia #BrainTumors #ACC #Vocabulary
The CAPP2 trial (long-term follow-up) reveals that 600 mg aspirin daily for ≥2 years cuts colorectal cancer (CRC) risk in Lynch syndrome patients by 35% 💊
#Lancet
#Onco404 #Cancer #Kanser #ClinicalTrials #LynchSyndrome #ColorectalCancer #EndometrialCancer #Aspirin #CancerPrevention #MedSky #OncSky
#Lancet
#Onco404 #Cancer #Kanser #ClinicalTrials #LynchSyndrome #ColorectalCancer #EndometrialCancer #Aspirin #CancerPrevention #MedSky #OncSky
May 22, 2025 at 3:33 PM
The CAPP2 trial (long-term follow-up) reveals that 600 mg aspirin daily for ≥2 years cuts colorectal cancer (CRC) risk in Lynch syndrome patients by 35% 💊
#Lancet
#Onco404 #Cancer #Kanser #ClinicalTrials #LynchSyndrome #ColorectalCancer #EndometrialCancer #Aspirin #CancerPrevention #MedSky #OncSky
#Lancet
#Onco404 #Cancer #Kanser #ClinicalTrials #LynchSyndrome #ColorectalCancer #EndometrialCancer #Aspirin #CancerPrevention #MedSky #OncSky
📌 OncoTerm - Word of the Day! 👋 OncoTerm - Günün Kelimesi! 📌
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #Cancer #Kanser #CancerAwareness #LynchSyndrome #RiskFactor #ColorectalCancer #EndometrialCancer #MedSky #OncSky #Vocabulary
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #Cancer #Kanser #CancerAwareness #LynchSyndrome #RiskFactor #ColorectalCancer #EndometrialCancer #MedSky #OncSky #Vocabulary
May 22, 2025 at 7:49 AM
📌 OncoTerm - Word of the Day! 👋 OncoTerm - Günün Kelimesi! 📌
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #Cancer #Kanser #CancerAwareness #LynchSyndrome #RiskFactor #ColorectalCancer #EndometrialCancer #MedSky #OncSky #Vocabulary
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #Cancer #Kanser #CancerAwareness #LynchSyndrome #RiskFactor #ColorectalCancer #EndometrialCancer #MedSky #OncSky #Vocabulary
A 2019 Global Burden of Disease Study reveals 44.4% of cancer deaths (4.45M) were linked to modifiable risk factors.
@thelancet.com
#Onco404 #Cancer #Kanser #PublicHealth #HalkSağlığı #CancerPrevention #GlobalHealth #Healthcare #RiskFactors #MedSky #OncSky
@thelancet.com
#Onco404 #Cancer #Kanser #PublicHealth #HalkSağlığı #CancerPrevention #GlobalHealth #Healthcare #RiskFactors #MedSky #OncSky
May 21, 2025 at 2:58 PM
A 2019 Global Burden of Disease Study reveals 44.4% of cancer deaths (4.45M) were linked to modifiable risk factors.
@thelancet.com
#Onco404 #Cancer #Kanser #PublicHealth #HalkSağlığı #CancerPrevention #GlobalHealth #Healthcare #RiskFactors #MedSky #OncSky
@thelancet.com
#Onco404 #Cancer #Kanser #PublicHealth #HalkSağlığı #CancerPrevention #GlobalHealth #Healthcare #RiskFactors #MedSky #OncSky
📌 OncoTerm - Word of the Day! 👋 OncoTerm - Günün Kelimesi! 📌
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #cancer #kanser #cancerawareness #riskfactor #medsky #oncsky #smoking #alcohol #obesity #genetics #familyhistory #vocabulary
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #cancer #kanser #cancerawareness #riskfactor #medsky #oncsky #smoking #alcohol #obesity #genetics #familyhistory #vocabulary
May 21, 2025 at 7:14 AM
📌 OncoTerm - Word of the Day! 👋 OncoTerm - Günün Kelimesi! 📌
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #cancer #kanser #cancerawareness #riskfactor #medsky #oncsky #smoking #alcohol #obesity #genetics #familyhistory #vocabulary
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #cancer #kanser #cancerawareness #riskfactor #medsky #oncsky #smoking #alcohol #obesity #genetics #familyhistory #vocabulary